Thursday after the bell, clinical development solutions provider Medidata Solutions, Inc. (MDSO) turned to a profit for the third-quarter, compared to a loss in the year-ago period on a 27% increase in revenue.
Medidata's third-quarter net profit was $1.6 million or $0.06 per share, compared with a loss of $3.4 million or $0.51 per share in the year-ago period.
Non-GAAP net income was $3.5 million, compared with a loss of $2.1 million in the prior-year period. On a per share basis, non-GAAP net income was $0.15, compared to a loss of $0.32.
Analysts polled by Thomson Reuters expected earnings of $0.04 for the quarter. Analysts' estimates typically exclude one-time items.
Medidata's total revenue increased 27% to $35.21 million from $27.81 in the year-earlier quarter. Analysts expected the company to post revenue of $33.62 million.
Segment-wise, revenue from application services shot up 36% to $25.95 million from $19.13 million, while revenue from professional services increased to $9.26 million from $8.67 million in the year-earlier period.
Total operating costs and expenses increased to $20.13 million from $18.09 million in the prior-year period.
For the nine-month period, net income was $3.44 million or $0.17 per share, compared to a loss of $17.85 million or $2.72 per share. Revenue increased to $102.84 million from $74.54 million a year earlier.
For the fourth-quarter, Medidata expects to report GAAP net income of between $0.4 million and $1.4 million and non-GAAP net income between $2.3 million and $3.3 million. The company also expects revenue between $35.2 million and $36.2 million. Analysts expect the company to report revenue of $34.78 million for the fourth quarter.
For the full year, Medidata expects GAAP net income between $3.8 million and $4.8 million and non-GAAP net income between $10.5 million and $11.5 million. It also increased its previous revenue guidance in the range of $135 million and $137 million to the range of $138 million and $139 million. Analysts expect the company to post revenue of $136.06 million.
MDSO closed Thursday's regular trading session at $15.40, up $0.19, on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.